Jochen Gann
Directeur Général chez Boehringer Ingelheim Finanzierungs GmbH
Profil
Jochen Gann is currently a Co-Managing Director at Boehringer Ingelheim Finanzierungs GmbH.
He previously worked as a Non-Executive Director at Hikma Pharmaceuticals Plc from 2016 to 2020.
Prior to that, he held Managing Director positions at Degussa Bank AG, Head-Tax position at Boehringer Ingelheim GmbH, Head-Treasury Controlling position at Hoechst AG, Global Head-Corporate Finance & Corporate VP position at C.H.
Boehringer Sohn AG & Co. KG, and Head-Corporate Treasury position at Cognis GmbH.
Dr. Gann holds an MBA from the University of Karlsruhe and a doctorate from the University of Hohenheim.
Postes actifs de Jochen Gann
| Sociétés | Poste | Début |
|---|---|---|
Boehringer Ingelheim Finanzierungs GmbH
 Boehringer Ingelheim Finanzierungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968. | Directeur Général | - |
Anciens postes connus de Jochen Gann
| Sociétés | Poste | Fin |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 25/06/2020 |
C.H. Boehringer Sohn AG & Co. KG
 C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Directeur Financier/CFO | - |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Corporate Officer/Principal | - |
Degussa Bank AG
 Degussa Bank AG Investment ManagersFinance Degussa Bank AG (Degussa Bank) is the investment management subsidiary of Degussa Bank Beteiligungsgesellschaft mbH in Germany. Based in Frankfurt, the firm specializes in private banking, brokerage, insurance products and retail banking for private investors. They manage mutual funds which are administered by their partner, Universal Investment GmbH. | Directeur Général | - |
Cognis GmbH
 Cognis GmbH Chemicals: SpecialtyProcess Industries Cognis GmbH is a supplier of specialty chemicals and nutritional ingredients. Their products are used in industrial markets encompassing home care, nutrition and health, ion-transfer technology and institutional cleaning. The company was founded in 1999 and is based in Monheim am Rhein, Germany. | Corporate Officer/Principal | - |
Formation de Jochen Gann
| University of Karlsruhe | Masters Business Admin |
| University of Hohenheim | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 6 |
|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Degussa Bank AG
Degussa Bank AG Investment ManagersFinance Degussa Bank AG (Degussa Bank) is the investment management subsidiary of Degussa Bank Beteiligungsgesellschaft mbH in Germany. Based in Frankfurt, the firm specializes in private banking, brokerage, insurance products and retail banking for private investors. They manage mutual funds which are administered by their partner, Universal Investment GmbH. | Finance |
Cognis GmbH
Cognis GmbH Chemicals: SpecialtyProcess Industries Cognis GmbH is a supplier of specialty chemicals and nutritional ingredients. Their products are used in industrial markets encompassing home care, nutrition and health, ion-transfer technology and institutional cleaning. The company was founded in 1999 and is based in Monheim am Rhein, Germany. | Process Industries |
Boehringer Ingelheim Finanzierungs GmbH
Boehringer Ingelheim Finanzierungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968. | Finance |